International Biotechnology Trust’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $3.17M | Sell |
154,000
-34,000
| -18% | -$700K | 1.07% | 29 |
|
|
2023
Q2 | $5.54M | Buy |
188,000
+101,425
| +117% | +$2.99M | 1.69% | 21 |
|
|
2023
Q1 | $1.99M | Buy |
86,575
+48,575
| +128% | +$1.12M | 0.56% | 40 |
|
|
2022
Q4 | $1.06M | Hold |
38,000
| – | – | 0.33% | 49 |
|
|
2022
Q3 | $1.17M | Buy |
38,000
+36,882
| +3,299% | +$1.13M | 0.37% | 49 |
|
|
2022
Q2 | $38K | Sell |
1,118
-36,882
| -97% | -$1.25M | 0.4% | 51 |
|
|
2022
Q1 | $8.19M | Buy |
38,000
+12,000
| +46% | +$2.59M | 1.85% | 21 |
|
|
2021
Q4 | $1.16M | Buy |
+26,000
| New | +$1.16M | 0.26% | 54 |
|